| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Biocardia, Inc. (BCDA) has 9 insiders with recent SEC Form 4 filings, including 6 buys and 4 sells. BCDA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 293.3K | $283.5K | - | |
| CFO | 106.2K | $102.7K | - | |
| VP | 47.0K | $45.5K | - | |
| Dir | 15.7K | $15.2K | - | |
| Dir | 15.6K | $15.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 21, 2018 | McClung David | Chief Financial Officer | Buy | 750 | $1.90 | $1,425.00 | New | |
| Mar 20, 2018 | Altman Peter47 | President And CEO | Buy | 5,000 | $2.03 | $10,150.00 | +0.7% | |
| Mar 1, 2017 | Stertzer Simon H | Director | Buy | 100,000 | $0.64 | $64,150.00 | +2.1% | |
| Jan 9, 2017 | Stertzer Simon H | Director | Buy | 10,000 | $0.82 | $8,228.00 | - | |
| Dec 22, 2016 | Stertzer Simon H | Director | Buy | 72,600 | $0.51 | $37,026.00 | +0.2% | |
| Dec 21, 2016 | Frost Phillip Md Et Al48 | 10% Owner | Sell | 19,230,769 | $0.13 | $2,499,999.97 | -12.8% | |
| Nov 1, 2016 | Stertzer Simon H | Director | Buy | 100,000 | $0.16 | $16,410.00 | +2.1% | |
| May 10, 2016 | Brooks Andrew A | CEO | Sell | 63,560,031 | $0.10 | $6,356,003.10 | -100% | |
| May 10, 2016 | Richards Ronald N. | Director | Sell | 872,205 | $0.10 | $87,220.50 | -100% | |
| May 10, 2016 | Morgan Thomas H. | Director | Sell | 7,531,004 | $0.10 | $753,100.40 | -99.5% |